FFAR4 and type 2 diabetes mellitus: On the basis ofpharmacological data, the role of GPR120 agonists in the managementof T2DM and other diseases has been proven, including cancer and inflammatoryconditions; pharmaceutical companies used this information to findnew and selective GPR120 agonists, although in most cases their therapeuticefficacy was not evaluated.